 | • レポートコード：GIR-22F3893 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2~3営業日） • 産業分類：化学＆材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global High Purity Heparin Sodium Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の高純度ヘパリンナトリウムの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 高純度ヘパリンナトリウム市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・未分画ヘパリン、低分子ヘパリン アプリケーション別セグメントは次のように区分されます。 ・静脈血栓塞栓症治療、妊娠合併症、心房細動・粗動除細動、その他 世界の高純度ヘパリンナトリウム市場の主要な市場プレーヤーは以下のとおりです。 ・Hepalink、Changshan Pharm、Qianhong Bio-pharma、Opocrin、Pfizer、Aspen Oss、King-friend Biochemical Pharmaceutical、Bioibérica、Dongcheng Biochemicals、Jiulong Biochemicals、Tiandong、Xinbai、Yino Pharma Limited、Deebio 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、高純度ヘパリンナトリウム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な高純度ヘパリンナトリウムメーカーの企業概要、2019年～2022年までの高純度ヘパリンナトリウムの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な高純度ヘパリンナトリウムメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別高純度ヘパリンナトリウムの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの高純度ヘパリンナトリウムのタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での高純度ヘパリンナトリウム市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および高純度ヘパリンナトリウムの産業チェーンを掲載しています。 ・第13、14、15章では、高純度ヘパリンナトリウムの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 高純度ヘパリンナトリウムの概要 - タイプ別分析（2017年vs2021年vs2028年）：未分画ヘパリン、低分子ヘパリン - アプリケーション別分析（2017年vs2021年vs2028年）：静脈血栓塞栓症治療、妊娠合併症、心房細動・粗動除細動、その他 - 世界の高純度ヘパリンナトリウム市場規模・予測 - 世界の高純度ヘパリンナトリウム生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Hepalink、Changshan Pharm、Qianhong Bio-pharma、Opocrin、Pfizer、Aspen Oss、King-friend Biochemical Pharmaceutical、Bioibérica、Dongcheng Biochemicals、Jiulong Biochemicals、Tiandong、Xinbai、Yino Pharma Limited、Deebio ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：未分画ヘパリン、低分子ヘパリン ・アプリケーション別分析2017年-2028年：静脈血栓塞栓症治療、妊娠合併症、心房細動・粗動除細動、その他 ・高純度ヘパリンナトリウムの北米市場分析 - 高純度ヘパリンナトリウムの北米市場：タイプ別市場規模2017年-2028年 - 高純度ヘパリンナトリウムの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・高純度ヘパリンナトリウムのヨーロッパ市場分析 - ：高純度ヘパリンナトリウムのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：高純度ヘパリンナトリウムのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・高純度ヘパリンナトリウムのアジア太平洋市場分析 - 高純度ヘパリンナトリウムのアジア太平洋市場：タイプ別市場規模2017年-2028年 - 高純度ヘパリンナトリウムのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・高純度ヘパリンナトリウムの南米市場分析 - 高純度ヘパリンナトリウムの南米市場：タイプ別市場規模2017年-2028年 - 高純度ヘパリンナトリウムの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・高純度ヘパリンナトリウムの中東・アフリカ市場分析 - 高純度ヘパリンナトリウムの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 高純度ヘパリンナトリウムの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The High Purity Heparin Sodium market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global High Purity Heparin Sodium market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Treatment of Venous Thromboembolism accounting for % of the High Purity Heparin Sodium global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Unfractionated Heparin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of High Purity Heparin Sodium include Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
High Purity Heparin Sodium market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Unfractionated Heparin
Low Molecular Heparin
Market segment by Application can be divided into
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Other
The key market players for global High Purity Heparin Sodium market are listed below:
Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioibérica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma Limited
Deebio
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe High Purity Heparin Sodium product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of High Purity Heparin Sodium, with price, sales, revenue and global market share of High Purity Heparin Sodium from 2019 to 2022.
Chapter 3, the High Purity Heparin Sodium competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the High Purity Heparin Sodium breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and High Purity Heparin Sodium market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of High Purity Heparin Sodium.
Chapter 13, 14, and 15, to describe High Purity Heparin Sodium sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 High Purity Heparin Sodium Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global High Purity Heparin Sodium Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Unfractionated Heparin
1.2.3 Low Molecular Heparin
1.3 Market Analysis by Application
1.3.1 Overview: Global High Purity Heparin Sodium Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.3.5 Other
1.4 Global High Purity Heparin Sodium Market Size & Forecast
1.4.1 Global High Purity Heparin Sodium Sales in Value (2017 & 2021 & 2028)
1.4.2 Global High Purity Heparin Sodium Sales in Volume (2017-2028)
1.4.3 Global High Purity Heparin Sodium Price (2017-2028)
1.5 Global High Purity Heparin Sodium Production Capacity Analysis
1.5.1 Global High Purity Heparin Sodium Total Production Capacity (2017-2028)
1.5.2 Global High Purity Heparin Sodium Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 High Purity Heparin Sodium Market Drivers
1.6.2 High Purity Heparin Sodium Market Restraints
1.6.3 High Purity Heparin Sodium Trends Analysis
2 Manufacturers Profiles
2.1 Hepalink
2.1.1 Hepalink Details
2.1.2 Hepalink Major Business
2.1.3 Hepalink High Purity Heparin Sodium Product and Services
2.1.4 Hepalink High Purity Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Changshan Pharm
2.2.1 Changshan Pharm Details
2.2.2 Changshan Pharm Major Business
2.2.3 Changshan Pharm High Purity Heparin Sodium Product and Services
2.2.4 Changshan Pharm High Purity Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Qianhong Bio-pharma
2.3.1 Qianhong Bio-pharma Details
2.3.2 Qianhong Bio-pharma Major Business
2.3.3 Qianhong Bio-pharma High Purity Heparin Sodium Product and Services
2.3.4 Qianhong Bio-pharma High Purity Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Opocrin
2.4.1 Opocrin Details
2.4.2 Opocrin Major Business
2.4.3 Opocrin High Purity Heparin Sodium Product and Services
2.4.4 Opocrin High Purity Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer High Purity Heparin Sodium Product and Services
2.5.4 Pfizer High Purity Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Aspen Oss
2.6.1 Aspen Oss Details
2.6.2 Aspen Oss Major Business
2.6.3 Aspen Oss High Purity Heparin Sodium Product and Services
2.6.4 Aspen Oss High Purity Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 King-friend Biochemical Pharmaceutical
2.7.1 King-friend Biochemical Pharmaceutical Details
2.7.2 King-friend Biochemical Pharmaceutical Major Business
2.7.3 King-friend Biochemical Pharmaceutical High Purity Heparin Sodium Product and Services
2.7.4 King-friend Biochemical Pharmaceutical High Purity Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bioibérica
2.8.1 Bioibérica Details
2.8.2 Bioibérica Major Business
2.8.3 Bioibérica High Purity Heparin Sodium Product and Services
2.8.4 Bioibérica High Purity Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Dongcheng Biochemicals
2.9.1 Dongcheng Biochemicals Details
2.9.2 Dongcheng Biochemicals Major Business
2.9.3 Dongcheng Biochemicals High Purity Heparin Sodium Product and Services
2.9.4 Dongcheng Biochemicals High Purity Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Jiulong Biochemicals
2.10.1 Jiulong Biochemicals Details
2.10.2 Jiulong Biochemicals Major Business
2.10.3 Jiulong Biochemicals High Purity Heparin Sodium Product and Services
2.10.4 Jiulong Biochemicals High Purity Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Tiandong
2.11.1 Tiandong Details
2.11.2 Tiandong Major Business
2.11.3 Tiandong High Purity Heparin Sodium Product and Services
2.11.4 Tiandong High Purity Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Xinbai
2.12.1 Xinbai Details
2.12.2 Xinbai Major Business
2.12.3 Xinbai High Purity Heparin Sodium Product and Services
2.12.4 Xinbai High Purity Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Yino Pharma Limited
2.13.1 Yino Pharma Limited Details
2.13.2 Yino Pharma Limited Major Business
2.13.3 Yino Pharma Limited High Purity Heparin Sodium Product and Services
2.13.4 Yino Pharma Limited High Purity Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Deebio
2.14.1 Deebio Details
2.14.2 Deebio Major Business
2.14.3 Deebio High Purity Heparin Sodium Product and Services
2.14.4 Deebio High Purity Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 High Purity Heparin Sodium Breakdown Data by Manufacturer
3.1 Global High Purity Heparin Sodium Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global High Purity Heparin Sodium Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in High Purity Heparin Sodium
3.4 Market Concentration Rate
3.4.1 Top 3 High Purity Heparin Sodium Manufacturer Market Share in 2021
3.4.2 Top 6 High Purity Heparin Sodium Manufacturer Market Share in 2021
3.5 Global High Purity Heparin Sodium Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and High Purity Heparin Sodium Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global High Purity Heparin Sodium Market Size by Region
4.1.1 Global High Purity Heparin Sodium Sales in Volume by Region (2017-2028)
4.1.2 Global High Purity Heparin Sodium Revenue by Region (2017-2028)
4.2 North America High Purity Heparin Sodium Revenue (2017-2028)
4.3 Europe High Purity Heparin Sodium Revenue (2017-2028)
4.4 Asia-Pacific High Purity Heparin Sodium Revenue (2017-2028)
4.5 South America High Purity Heparin Sodium Revenue (2017-2028)
4.6 Middle East and Africa High Purity Heparin Sodium Revenue (2017-2028)
5 Market Segment by Type
5.1 Global High Purity Heparin Sodium Sales in Volume by Type (2017-2028)
5.2 Global High Purity Heparin Sodium Revenue by Type (2017-2028)
5.3 Global High Purity Heparin Sodium Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global High Purity Heparin Sodium Sales in Volume by Application (2017-2028)
6.2 Global High Purity Heparin Sodium Revenue by Application (2017-2028)
6.3 Global High Purity Heparin Sodium Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America High Purity Heparin Sodium Sales by Type (2017-2028)
7.2 North America High Purity Heparin Sodium Sales by Application (2017-2028)
7.3 North America High Purity Heparin Sodium Market Size by Country
7.3.1 North America High Purity Heparin Sodium Sales in Volume by Country (2017-2028)
7.3.2 North America High Purity Heparin Sodium Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe High Purity Heparin Sodium Sales by Type (2017-2028)
8.2 Europe High Purity Heparin Sodium Sales by Application (2017-2028)
8.3 Europe High Purity Heparin Sodium Market Size by Country
8.3.1 Europe High Purity Heparin Sodium Sales in Volume by Country (2017-2028)
8.3.2 Europe High Purity Heparin Sodium Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific High Purity Heparin Sodium Sales by Type (2017-2028)
9.2 Asia-Pacific High Purity Heparin Sodium Sales by Application (2017-2028)
9.3 Asia-Pacific High Purity Heparin Sodium Market Size by Region
9.3.1 Asia-Pacific High Purity Heparin Sodium Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific High Purity Heparin Sodium Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America High Purity Heparin Sodium Sales by Type (2017-2028)
10.2 South America High Purity Heparin Sodium Sales by Application (2017-2028)
10.3 South America High Purity Heparin Sodium Market Size by Country
10.3.1 South America High Purity Heparin Sodium Sales in Volume by Country (2017-2028)
10.3.2 South America High Purity Heparin Sodium Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa High Purity Heparin Sodium Sales by Type (2017-2028)
11.2 Middle East & Africa High Purity Heparin Sodium Sales by Application (2017-2028)
11.3 Middle East & Africa High Purity Heparin Sodium Market Size by Country
11.3.1 Middle East & Africa High Purity Heparin Sodium Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa High Purity Heparin Sodium Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of High Purity Heparin Sodium and Key Manufacturers
12.2 Manufacturing Costs Percentage of High Purity Heparin Sodium
12.3 High Purity Heparin Sodium Production Process
12.4 High Purity Heparin Sodium Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 High Purity Heparin Sodium Typical Distributors
13.3 High Purity Heparin Sodium Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer